Clinical Characteristics and Genetic Evolution of Skull Base Chondrosarcomas
Journal of Neurological Surgery Part B: Skull Base · 01.02.2024 · 85 (S 01 S 01) · S1-S398
DOI: 10.1055/s-0044-1779832 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurological Surgery Part B: Skull Base, erschienen am 01.02.2024. Verfasst von Jessica C. Eaton und 11 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Chondrosarcomas are uncommon tumors, with an incidence of 0.1-0.3 cases per 100,000 people. Grade 1 tumors are usually indolent and slow growing; however, high-grade (2 and 3) tumors display rapid progression, early metastasis, and poor overall survival rate. Current treatment consists of maximal safe surgical resection. The addition of adjuvant radiation reduces 5-year mortality by about 50%, but recurrence rates at 5 years are still over 30%. Targeted treatment options are needed to improve outcomes for patients with these tumors. Genomic instability is a characteristic of almost all human cancers. Tumor adaptation is known to be a significant obstacle to successful treatment of cancer. When patients have local recurrence of skull base tumors, they often require repeat surgical resection for relief of symptoms caused by mass effect on important neural structures. In patients that have undergone previous surgery followed by adjuvant therapies, this gives the opportunities to use advanced sequencing techniques to compare the transcriptome of the patients’ tumors before and after treatment to ascertain what changes have taken place. We present a cohort of patients with skull base chondrosarcomas. We describe clinical characteristics and outcomes of these patients. In three patients, resection was performed at least one additional time, providing us with at least 2 tissue samples from each patient. We performed whole exome sequencing to identify potential cancer-driving mutations, and compared the multiple samples from each patients to understand how the tumors might change over time.
Methods
We performed a retrospective cohort analysis of 38 patients with skull base chondrosarcomas, describing clinical characteristics and outcomes. Three patients underwent multiple resections, with one patient having 2 samples obtained, and 2 patients having 3 samples obtained. Whole exome sequencing was performed on these samples and changes over time were evaluated.
Results
A total of 38 patients with skullbase chondrosarcomas underwent surgery between 2000 and 2020. Mean follow-up time was 83.3 ± 107.7 months. Mean progression free survival time was 54.4 ± 71.5 months. Mortality was 15.8%. Whole exome sequencing was performed on the selected tumor samples, and 22 known cancer-driving mutations were selected for evaluation. Patient A originally carried 17 of the 22 mutations. Her tumor was genetically identical. Patient B originally carried 3 of the 22 mutations. Her second sample contained 2 mutations, gaining a KMT2C mutation and losing a NOTCH1 mutation. Her third sample, obtained after stereotactic radiosurgery treatment, had only an IDH1 mutation. Patient C’s originally resected tumor contained 2 mutations. He then received proton radiation. His second tumor contained the previously seen NOTCH3 and IDH1 mutation, but also TNC and SYNE1, and his third tumor contained KMT2C, lost SYNE1, lost NOTCH3, and lost IDH1. Patient C died shortly after his third resection.
Conclusion
Whole exome sequencing reveals a wide variety of differences in extent and type of genetic mutation in skull base chondrosarcomas. While radiation is often employed for higher grade lesions, this may alter the genetic signature of the tumors. This must be considered when developing treatment strategies. Publication History Article published online: 05 February 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Eaton, J. C., Parada, C. A., Parrish, O., Tucker, M., Zhao, Z., Delegard, J., Lassiter, E., Tyrtova, E., Emerson, S., Ruzevick, J., Cranmer, L., & Ferreira, M. (2024). Clinical Characteristics and Genetic Evolution of Skull Base Chondrosarcomas. Journal of Neurological Surgery Part B: Skull Base, 85(S 01 S 01), S1-S398. https://doi.org/10.1055/s-0044-1779832
Vancouver
Eaton JC, Parada CA, Parrish O, Tucker M, Zhao Z, Delegard J, et al. Clinical Characteristics and Genetic Evolution of Skull Base Chondrosarcomas. Journal of Neurological Surgery Part B: Skull Base. 2024;85(S 01 S 01):S1-S398. doi:10.1055/s-0044-1779832
BibTeX
@article{Eaton2024,
author = {Eaton, Jessica C. and Parada, Carolina A. and Parrish, Oscar and Tucker, Mallory and Zhao, Zirun and Delegard, Jennifer and Lassiter, Eric and Tyrtova, Evgeniya and Emerson, Samuel and Ruzevick, Jacob and Cranmer, Lee and Ferreira, Manuel},
title = {Clinical Characteristics and Genetic Evolution of Skull Base Chondrosarcomas},
journal = {Journal of Neurological Surgery Part B: Skull Base},
year = {2024},
volume = {85},
number = {S 01 S 01},
pages = {S1--S398},
doi = {10.1055/s-0044-1779832}
}
EUVIMED